(MENAFN- Quintile Reports) The Global Cancer Biopsy Market ... awareness related to cervical, vulvar, and vaginal cancers, encouraging regular screenings. An example is the National Black Family ...

The global Breast Biopsy Devices Market, valued at US$2,255.0 million in 2024, is forecasted to grow at a robust CAGR of 6.5%, reaching US$2,384.1 million in 2025 and an impressive US$3,261.7 million ...

“Usually, women are unaware that they have fibroids in the uterus, only finding out during an ultrasound scan. If left untreated, these growths can disrupt daily life, especially if symptomatic, such ...

An analysis of the CALLA study shows that ctDNA is detected an average of 5.5 months before radiographic progression.

Pune: A mobile cancer detecting van, making rounds of rural areas in Pune circle since Feb 9, has diagnosed 144 new patients ...

Dublin, May 28, 2025 (GLOBE NEWSWIRE) -- The "Europe Cervical Cancer Screening Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" report has been added to ...

hysteroscopy and cervical biopsy. The guidance recommends that clinicians offer local anesthetics for IUD insertions, including lidocaine-prilocaine cream, lidocaine spray and paracervical block.

including cervical biopsy, endometrial biopsy and intrauterine imaging. To decrease the pain associated with these procedures, ACOG now recommends either an anesthetic cream, a spray or an ...

Dublin, May 28, 2025 (GLOBE NEWSWIRE) -- The "Europe Cervical Cancer Screening Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" report has been added to ResearchAndMarkets ...

endometrial biopsy, hysteroscopy, intrauterine imaging and cervical biopsy. The guidelines include recommendations such as offering local anesthetics like lidocaine injection, spray or cream for ...

The report says Illumina is putting an $8 billion ... position in clinical diagnostics in recent years. In January, for example, Illumina joined forces with Roche on a 15-year alliance focusing ...

The feasibility of CNB for high-risk cervical lymph nodes was ... for malignant lymph nodes at the second biopsy. This study still has some limitations. First, our study was a single-centre study with ...